Dr Karen Van Baelen unveils critical findings at SABCS 2023 from the UPTIDER program. Key insights reveal unseen metastases in lobular breast cancer, challenging current diagnostic approaches. Discoveries emphasise the vital role of detailed microscopic examinations and the persistence of ER status, urging a reevaluation of treatment strategies. Discover these vital insights. 👇 For all SABCS 2023 videos, find the link in the comments! #SABCS2023 #BreastCancerAwareness #UPTIDERStudy #OncologyInnovation
MediMix’s Post
More Relevant Posts
-
In this new retrospective study published in July, two #AI-powered mammography solutions were evaluated head-to-head, to compare results of breast cancer detection. #ProFoundAI performed significantly better than the other solution for breast cancer detection, particularly in patients with non-dense breasts (AUC, 0.93; P < .001). Explore the study: https://bit.ly/3WGGiLY #EarlyDetection, #BreastAI, #iCAD, #RadiologyAI
-
-
More and more data to confirm what we have been saying. Please reach out to me with any questions about our technology and platforms for Liquid Biopsy samples
"Our findings demonstrate an improved detection of ctDNA and CTCs by using larger plasma volumes," says new paper from Alba-Bernal et al. published in NPG's Breast Cancer journal. Their study looked at plasma volumes of up to 40 mL and the improved assay sensitivity and other performance parameters. Read it here: https://lnkd.in/dyDzfC5F #liquidbiopsy #SamplePrepMatters #cfDNA #CTCs #oncologyresearch #cancerresearch
-
-
Did you read our blog on the POETIC study? Ki67 has long been a crucial prognostic marker in breast cancer, offering potential as a predictive guide for treatment decisions. Our analysis of the landmark POETIC study delves deeper into Ki67, examining its connections with various clinico-pathological features. This study not only underscored the significance of Ki67 but also sheds light on the challenges associated with scoring it using immunohistochemistry (IHC). Discover more in our comprehensive blog: the links in our comments Is quantitative PCR the viable alternative to IHC for Ki67 scoring? #BreastCancerResearch #MedicalInsights
-
-
😎 Check out the #systematicreview "Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis" 👐 Authors: Arya Mariam Roy, Supritha Chintamaneni et al. 👉 Find the full paper here: https://lnkd.in/dufCkAKG
-
-
MD - Anaesthesiologist and Intensivist - Careggi University Hospital, Florence, Italy
We are happy to share with you our last study, published online yesterday, on Breast Cancer. We prospectively compared PICCs vs PICC-ports in terms of quality of life in women with breast cancer undergoing neoadjuvant chemotherapy. PICC-ports were definitively better accepted than PICCs, especially in younger patients. We think this adds important informations for choosing the most appropriate device in these patients. Hope you will enjoy it! #qualityoflife #breastcancer #vascularaccess #PICC #PICCport
-
These orthotopic models of NSCLC tumors are pivotal for testing new therapies and understanding resistance mechanisms. Kudos to Ulrich Jarry, Remy Pedeux and the team for their valuable contribution to lung cancer research! 🧬💊 #oncotrial #LungCancerResearch #CancerTherapies #PreclinicalModels #NSCLC #BiomedicalResearch #OncologyResearch https://lnkd.in/d_3J5zJy
-
-
Tune into our new series: Minutes With Markman! Listen in as Maurie Markman, MD, covers the broad landscape of info in #Oncology. This week, he discusses the evolution of breast and lung cancer management. Watch only on YouTube: https://lnkd.in/ejJJQtfF
-
-
Medical Oncologist, Researcher – Minsk City Clinical Oncologic Centre, ESO Ambassador
Veryinteresting data on ctDNA utility in early-stage NSCLC.
#AnnalsOfOncology: Circulating tumour DNA and radiological tumour volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. https://ow.ly/w21H50Qx5wS #LungCancer #NSCLC
-
-
Join us on the 28th of May, from 17:00-18:00, for the webinar 'Breast cancer diagnostics today: Is a sensitive liquid biopsy the missing piece?'. This webinar, featuring leading expert Professor Nicola Fusco, explores the applications of liquid biopsy - a minimally invasive approach analysing tumor DNA circulating in blood. #BreastCancer #LiveWebinar #LiquidBiopsy #CaresphereAcademy #SysmexLifeScience #SysmexBNL
-
A Rare Case of Bilateral Synchronous Male Breast Cancer: A Multimodality Approach You can see the free full text of the research by Cihan Özgür et al Link : https://lnkd.in/dWciYj47 #Breastcancer #breastultrasonography #magneticresonanceimaging #mammography #malebreastcancer #synchronousneoplasms
-
https://bit.ly/4883lU5